SELECTIVE ADSORBENT OF EDA (+) FIBRONECTIN
One of the important purposes of apheresis in immune diseases is to remove EDA (+) fibronectin, which becomes elevated in the plasma of patients with serious rheumatoid arthritis, SLE, and rejection of kidney graft. We developed EDA (+) fibronectin adsorbent (OHC-10), but as described previously, it...
Saved in:
Published in | Jinko Zoki Vol. 28; no. 1; pp. 118 - 122 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | Japanese |
Published |
JAPANESE SOCIETY FOR ARTIFICIAL ORGANS
01.01.1999
一般社団法人 日本人工臓器学会 |
Subjects | |
Online Access | Get full text |
ISSN | 0300-0818 1883-6097 |
DOI | 10.11392/jsao1972.28.118 |
Cover
Summary: | One of the important purposes of apheresis in immune diseases is to remove EDA (+) fibronectin, which becomes elevated in the plasma of patients with serious rheumatoid arthritis, SLE, and rejection of kidney graft. We developed EDA (+) fibronectin adsorbent (OHC-10), but as described previously, it adsorbed not only EDA (+) fibronectin but also AT III and lipids. We recently developed a new adsorbent (OHC-20) which dose not adsorb AT III. Using 1 ml of OHC-20, a single pass test of 40ml blood was performed in 3 volunteers. Reduction rates were calculated for EDA (+) fibronectin, AT III, fibrinogen, cholesterol, triglyceride, and platelets. The reduction rate of EDA (+) fibronectin was more than 40%. One ml of OHC-20 could adsorb EDA (+) fibronectin in more than 40ml of blood. The reduction rate of AT III was less than 10%. Cholesterol and triglyceride were adsorbed to only a small degree. OHC-20 might be practical for the reduction of EDA (+) fibronectin. |
---|---|
ISSN: | 0300-0818 1883-6097 |
DOI: | 10.11392/jsao1972.28.118 |